SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SUN PHARMA ADVANCED RESEARCH C

BSE: 532872 29 Jul 2025
Healthcare
₹ 161.9
Sun Pharma Advanced Research Company Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SUN PHARMA ADVANCED RESEARCH C - Share Price & Details

Market Cap
₹5,384
High /Low
258.0 / 109.0
Stock P/E
NA
Book Value
₹-6.8
Dividend Yield
0.0
ROCE
-298.0
ROE
₹NA
Face Value
1.0
PEG Ratio
NA
EVEBITDA
₹-17.4
Debt
265
CMP / FCF
-17.7
Debt to equity
₹0.45
NP Ann
-345
High price all time
594.0
Piotroski score
₹2.0
Graham Number
NA
No. Eq. Shares
32.4
Net CF
₹-3.87
Net profit
-345
Price to book value
NA
Interest Coverage
₹-37.8
Low price all time
35.2
Industry PE
33.8
Reserves
₹-253
Free Cash Flow
₹-372

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,3.25-4.52NA-18.440
SUN PHARMA ADVANCED RESEARCH C271.90-609.80271.90-1.885,384
SUVEN LIFE SCIENCES LTD.26.58-150.7014.67-0.695147
AARTI DRUGS LTD.5213.4486.45209.65.33493226.2

Peer Comparison Chart


About SUN PHARMA ADVANCED RESEARCH C

Sun Pharma Advanced Research Company Ltd., with Security Code 532872, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Sun Pharma Advanced Research Company Limited (532872) Gets Regulatory Approval - Phenomenal returns

(24 Jul 2025)
Sun Pharma Advanced Research Company Limited (532872) Gets Regulatory Approval ✌️【Trading Ideas】✌️ Our platform integrates global futures,...
Read more →

Macro Trends and Their Impact on Sun Pharma Advanced Research Company Limited (532872) - Unmatched market performance

(23 Jul 2025)
Macro Trends and Their Impact on Sun Pharma Advanced Research Company Limited (532872) ✌️【Market Focus】✌️ Imagine turning a $1,000...
Read more →

SPARC Confirms Pipeline Strength, No Capex Plans After Psoriasis Drug Setback — Profit Exclusive

(24 Jun 2025)
Sun Pharma Advanced Research Co. has told NDTV Profit that it expects no financial impact or need for fresh capital expenditure following...
Read more →

Sun Pharma Advanced Research shares tank 20% after psoriasis drug fails Phase 2 trials

(10 Jun 2025)
Sun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for psoriasis and...
Read more →

Sun Pharma Advanced Research hits 20% lower band; what's rattling Street?

(08 Jun 2025)
Sun Pharma Advanced Research Company (SPARC) shares slumped 20 per cent in trade on Wednesday, June 4, 2025, hitting its lower circuit at...
Read more →

SPARC shares fall 18% after Sun Pharma's key psoriasis drug fails to get desired outcome

(08 Jun 2025)
Shares of Sun Pharma Advanced Research Company (SPARC), a unit of India's largest drug maker Sun Pharmaceuticals Ltd. fell as much as 18% on...
Read more →

Company Updates